Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients.

Katarzyna Romejko Aleksandra RymarzKatarzyna SzamotulskaZbigniew BartoszewiczTomasz RozmyslowiczStanisław Niemczyk

Published in: Cells (2023)

Resistin concentrations rise with the increase of CV risk in CKD patients and thus resistin may contribute to the progression of cardiovascular risk in this group of patients. The relationship between resistin and CV risk is modified by PAI-1 concentrations.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis